Sagent Pharmaceuticals (SGNT) in Focus: Stock Falls 7.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 18, 7:34AM CST
Shares of Sagent Pharmaceuticals (SGNT) fell over 7% on the day. This continues the most recent downtrend for SGNT, as the stock is down over 17% in the past one month time frame. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future.
SGNT: 25.58 (+0.31), IG: 9.11 (-0.01)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Dec 17, 11:46AM CST
PTRY: 36.78 (+0.28), VIP: 4.07 (-0.26), CCM: 5.87 (-0.11), HGSH: 4.60 (-0.06), CLF: 6.06 (-0.09), ASPX: 49.93 (-0.10), SN: 9.91 (-0.71), NVGN: 2.40 (-0.09), NYNY: 7.89 (+0.32), FVE: 4.03 (-0.03), DRIV: 24.49 (+0.09), SGNL: 2.22 (-0.01), RT: 6.30 (+0.10), SFY: 4.47 (-0.06), VOLC: 17.95 (+0.02), WRES: 1.66 (-0.13), SGNT: 25.58 (+0.31), BBLU: 1.15 (-0.03), POZN: 7.86 (+0.07), XNCR: 16.83 (+0.77)
Ryanair Holdings (RYAAY) Jumps: Stock Adds 7.2% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Dec 05, 8:11AM CST
Ryanair Holdings plc (RYAAY) was a big mover last session, as the company saw its shares rise over 7% on the day.
LCI: 42.29 (+1.79), RYAAY: 68.61 (+0.09), SGNT: 25.58 (+0.31), IG: 9.11 (-0.01)
Otonomy (OTIC) Jumps: Stock Adds 5.7% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 02, 8:11AM CST
Otonomy, Inc. (OTIC) was a big mover last session, as the company saw its shares rise roughly 6% on the day.
LCI: 42.29 (+1.79), SGNT: 25.58 (+0.31), IG: 9.11 (-0.01), OTIC: 32.26 (+0.65)
Sagent (SGNT) Sees Hammer Chart Pattern: Time to Buy? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 21, 7:56AM CST
Sagent (SGNT) Sees Hammer Chart Pattern: Time to Buy?
SGNT: 25.58 (+0.31)
Sagent Chairman and CEO Jeff Yordon Inducted Into the UIC Chicago Area Entrepreneurship Hall of Fame
GlobeNewswire - Fri Nov 07, 8:35AM CST
Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) ("Sagent"
SGNT: 25.58 (+0.31)
Sagent Pharmaceuticals' (SGNT) CEO Jeff Yordon on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Nov 04, 8:09PM CST
SGNT: 25.58 (+0.31)
Sagent Pharmaceuticals (SGNT) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Nov 04, 7:55AM CST
SGNT: 25.58 (+0.31)
Sagent Pharmaceuticals beats by $0.12, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 6:06AM CST
SGNT: 25.58 (+0.31)
Sagent Pharmaceuticals Reports Third Quarter 2014 Financial Results
GlobeNewswire - Tue Nov 04, 6:00AM CST
Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced financial results for the quarter ended September 30, 2014.
SGNT: 25.58 (+0.31)
Sagent Pharma reports November 4
Seeking Alpha - at Seeking Alpha - Fri Oct 24, 3:07PM CDT
SGNT: 25.58 (+0.31)
Sagent Pharmaceuticals Sets Date and Time for Release of Third Quarter 2014 Financial Results
GlobeNewswire - Fri Oct 24, 3:00PM CDT
Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced that it will release financial results for the 2014 third quarter pre-market on Tuesday, November 4, 2014 and will host a teleconference and webcast at 9 a.m. ET to review the results.
SGNT: 25.58 (+0.31)
How Sagent Pharmaceuticals (SGNT) Stock Stands Out in a Strong Industry - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 17, 7:41AM CDT
Sagent Pharmaceuticals belongs to the Med-drugs industry, is a decent pick as it witnessed solid earnings estimate revision activity with a favorable Zacks Industry Rank.
SGNT: 25.58 (+0.31)
3 Stocks Spiking on Big Volume
at The Street - Tue Oct 14, 8:39AM CDT
Keep these stocks rising on unusual volume on your trading radar.
NJR: 59.92 (+0.85), FFIV: 135.11 (+1.17), SGNT: 25.58 (+0.31)
MEI Pharma (MEIP) Soars: Stock Adds 5.5% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 14, 7:51AM CDT
MEI Pharma, Inc. (MEIP) was a big mover last session, as its shares rose over 5% on the day.
ACRX: 6.61 (+0.06), SGNT: 25.58 (+0.31), HPTX: 21.91 (-0.08), MEIP: 3.90 (+0.11)
Auxilium Pharmaceuticals (AUXL) Jumps: Stock Rises 9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 10, 8:39AM CDT
Auxilium Pharmaceuticals Inc. (AUXL) was a big mover last session, as the company shares rose a little over 9% on the day.
SGNT: 25.58 (+0.31), HPTX: 21.91 (-0.08)
Surging Earnings Estimates Signal Good News for Sagent Pharmaceuticals (SGNT) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 09, 7:41AM CDT
Sagent Pharmaceuticals could be a solid choice for investors, as it witnessed solid activity on the earnings estimate revision front and also has a favorable Zacks Rank.
SGNT: 25.58 (+0.31)
Strong And Under The Radar: Sagent Pharmaceuticals (SGNT)
at The Street - Wed Oct 08, 1:16PM CDT
Trade-Ideas LLC identified Sagent Pharmaceuticals (SGNT) as a strong and under the radar candidate
SGNT: 25.58 (+0.31)
Zogenix (ZGNX) Shows Strength: Stock Adds 11.2% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 06, 8:39AM CDT
Zogenix, Inc. (ZGNX) was a big mover last session, as the company shares rose over 11% on the day.
LCI: 42.29 (+1.79), ZGNX: 1.20 (+0.04), SGNT: 25.58 (+0.31), HPTX: 21.91 (-0.08)
BioCryst Pharmaceuticals (BCRX) Jumps: Stock Up 12.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 06, 7:51AM CDT
BioCryst Pharmaceuticals, Inc. (BCRX) was a big mover last session, as the company shares rose over 12% on the day.
LCI: 42.29 (+1.79), BCRX: 11.83 (+0.76), SGNT: 25.58 (+0.31), HPTX: 21.91 (-0.08)